Indeed, studies on HNSCC have been published showing increased chemosensitization37, radiosensitization38 and susceptibility to HER1 inhibition (Cetuximab)36,38,39 after inhibiting the HER3 receptor. Here, EGFR is linked to head and neck squamous cell carcinoma.